StonvexLoading…
StonvexStonvexStonvexCore line items from AZN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $58.74B | $54.07B | $45.81B | $44.35B |
Operating Income | $13.74B | $10.00B | $8.19B | $3.76B |
Net Income | $10.23B | $7.04B | $5.96B | $3.29B |
EPS (Diluted) | $6.54 | $4.50 | $3.81 | $2.11 |
Total Assets | $114.07B | $104.03B | $101.12B | $96.48B |
Total Liabilities | $65.36B | $63.16B | $61.95B | $59.42B |
Cash & Equivalents | $5.71B | $5.49B | $5.84B | $6.17B |
Free Cash Flow OCF − CapEx | $11.77B | $9.94B | $8.98B | $8.72B |
Shares Outstanding | Not available | Not available | Not available | Not available |